07:00 , Aug 8, 2016 |  BioCentury  |  Product Development

Galvanizing bioelectronics

With disease biology expertise from GlaxoSmithKline plc and device development know-how from Verily Life Sciences LLC, newco Galvani Bioelectronics Ltd. plans to bring a commercial-grade bioelectronic therapeutic device to the clinic in about four years....